(ASND) Ascendis Pharma AS - Performance 28.3% in 12m

ASND performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.

Performance Rating 15.40%
#22 in Peer-Group
Rel. Strength 73.89%
#2005 in Stock-Universe
Total Return 12m 28.25%
#43 in Peer-Group
Total Return 5y 14.68%
#31 in Peer-Group
P/E Value
P/E Trailing -
P/E Forward -
High / Low USD
52 Week High 179.10 USD
52 Week Low 112.93 USD
Sentiment Value
VRO Trend Strength +-100 63.97
Buy/Sell Signal +-5 1.14
Support / Resistance Levels
Support
Resistance
12m Total Return: ASND (28.3%) vs XBI (-7%)
Total Return of Ascendis Pharma AS versus its related sector ETF XBI
5y Drawdown (Underwater) Chart
5 Year Drawdown / Underwater Chart for (ASND) Ascendis Pharma AS - Performance 28.3% in 12m

Top Performer in Biotechnology

Short Term Performance

Symbol 1w 1m 3m
ASND 1.14% 0.28% 22.1%
RGC 32.1% 38.7% 2,612%
VOR 80.2% 734% 237%
ABVC 20.1% 96.8% 319%

Long Term Performance

Symbol 6m 12m 5y
ASND 24.2% 28.3% 14.7%
RGC 0.0% 0.0% 8,221%
DRUG -31.5% 2,602% 5.07%
RGLS 426% 392% -1.09%

Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating

Symbol 1m 12m 5y P/E P/E Forward PEG EPS Stability EPS CAGR
GILD NASDAQ
Gilead Sciences
3.23% 73% 77.8% 22.7 13.6 0.23 28.3% -3.71%
UTHR NASDAQ
United Therapeutics
-9.1% -6.38% 147% 11.3 10.5 1.43 74.6% 16.1%
AMGN NASDAQ
Amgen
3.91% -0.97% 36% 25.4 13.4 0.93 0.60% 41%
BIM PA
Biomerieux
1.34% 27.6% -4.82% 33.1 25.8 1.55 -38.5% -25.1%
NBIX NASDAQ
Neurocrine Biosciences
3.69% -7.17% 1.14% 43 24.8 0.27 18.7% -34.3%
KMDA NASDAQ
Kamada
18.3% 43% -4.19% 27.6 22.4 0.9 68.9% 36.8%
PTCT NASDAQ
PTC Therapeutics
-4.03% 58.7% -9.25% 7.71 6.26 0.81 - 68%
ERF PA
Eurofins Scientific SE
6.2% 28.7% 15.2% 28.9 15.4 0.64 -62.1% -19.3%

Performance Comparison: ASND vs XBI vs S&P 500

XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ASND
Total Return (including Dividends) ASND XBI S&P 500
1 Month 0.28% 3.36% 5.25%
3 Months 22.09% 15.73% 24.13%
12 Months 28.25% -7.02% 14.15%
5 Years 14.68% -24.21% 111.83%

Trend Score (consistency of price movement) ASND XBI S&P 500
1 Month -3.4% 4.4% 81%
3 Months 78.1% 78.8% 96.9%
12 Months 67.1% -85.8% 44.9%
5 Years -8.4% -52.6% 84%

Relative Strength (compared with Indexes) Rank in Peer Group vs. XBI vs. S&P 500
1 Month %th52.50 -2.97% -4.72%
3 Month %th55.00 5.49% -1.65%
12 Month %th79.00 37.94% 12.35%
5 Years %th85.00 51.32% -45.86%

FAQs

Does Ascendis Pharma AS (ASND) outperform the market?

Yes, over the last 12 months ASND made 28.25%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%. Over the last 3 months ASND made 22.09%, while XBI made 15.73%.

Performance Comparison ASND vs Indeces and Sectors

Above 0 means better perfomance compared to Symbol in this Timeframe

ASND vs. Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -0.6% -5% 18.5% 14%
US NASDAQ 100 QQQ -0.3% -5% 17.9% 16%
German DAX 40 DAX 1.6% 1.7% 6.4% -1%
Shanghai Shenzhen CSI 300 CSI 300 -0.4% -3% 15.1% 8%
Hongkong Hang Seng HSI -0.2% -5.8% -0.9% -10%
India NIFTY 50 INDA 1.3% -3.2% 18.2% 29%
Brasil Bovespa EWZ -3% -8.5% -6.6% 18%

ASND vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 0.8% -5.6% 14.4% 4%
Consumer Discretionary XLY -0.1% -2.9% 26.2% 10%
Consumer Staples XLP -0.9% -0.4% 16.9% 19%
Energy XLE -0.9% -6.8% 22.6% 28%
Financial XLF -1.3% -4.8% 13.6% -2%
Health Care XLV -0% -1.9% 25.9% 33%
Industrial XLI -0.7% -3.9% 10.7% 3%
Materials XLB -2.8% -4% 14% 22%
Real Estate XLRE -0.5% -0.7% 18.8% 15%
Technology XLK -1.3% -8.4% 16.2% 17%
Utilities XLU 0.5% -1.5% 15.3% 5%
Aerospace & Defense XAR 1.6% -6.8% -0.1% -21%
Biotech XBI -1.6% -3.1% 31.7% 35%
Homebuilder XHB -3.1% -6.7% 25.7% 23%
Retail XRT -3.1% -4.7% 22.8% 17%

ASND vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -1.5% -8.16% 26.9% 36%
Natural Gas UNG 8.9% 10.1% 35.3% 30%
Gold GLD -0.8% 1.5% -2.1% -11%
Silver SLV -1.6% -6.6% 1.2% 11%
Copper CPER 0.4% -4.3% 1.4% 17%

ASND vs. Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 1.3% -0.8% 21.9% 30%
iShares High Yield Corp. Bond HYG 0.6% -1.3% 19.6% 18%